3 completed, 1 not yet recruiting, 1 recruiting. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Not yet recruiting 1, Recruiting 1 |
Follow Nasopharynx Cancer: new trials by email Literature Review of Nasopharynx Cancer trials Research Report on Nasopharynx Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC GEP (Gemcitabine, Recombinant Human Endostatin, and Carrellizumab) Combined With High-low-dose Radiotherapy - Nasopharynx Cancer | Phase 2 | Not yet recruiting | Zhejiang Cancer Hospital | 41 | 2024-09-30 | 2024-09-25 |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma Nivolumab, Cisplatin, 5-Fluorouracil - Nasopharyngeal Carcinoma, Nasopharyngeal Cancer | Phase 2 | Recruiting | German Society for Pediatric Oncology and Hematology GPOH gGmbH | 57 | 2023-01-10 | 2024-05-16 |
| Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma Nab-paclitaxel, Cisplatin and Fluorouracil, concurrent chemoradiotherapy - Nasopharyngeal Carcinoma, Nasopharyngeal Cancer | Phase 2 | Completed | Guangxi Medical University | 60 | 2019-03-28 | 2025-12-11 |
| Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma Pembrolizumab, Cetuximab - HNSCC, Lip SCC | Phase 2 | Completed | University of California, San Diego | 78 | 2017-03-28 | 2026-10-01 |
| Adaptive Radiotherapy for Head and Neck Cancer Adaptive Radiotherapy - Head and Neck Cancer, Paranasal Sinus Cancer | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 64 | 2017-03-15 | 2021-10-26 |
Nasopharyngeal Neoplasms (5) · Head and Neck Neoplasms (2) · Hypopharyngeal Neoplasms (2) · Laryngeal Neoplasms (2) · Mouth Neoplasms (2) · Nasopharyngeal Carcinoma (2) · Oropharyngeal Neoplasms (2) · Neoplasm Metastasis (1) · Paranasal Sinus Neoplasms (1) · Recurrence (1) · Squamous Cell Carcinoma of Head and Neck (1)
Nasopharyngeal Diseases (5) · Neoplasms (5) · Neoplasms by Site (5) · Otorhinolaryngologic Diseases (5) · Otorhinolaryngologic Neoplasms (5) · Pharyngeal Diseases (5) · Pharyngeal Neoplasms (5) · Stomatognathic Diseases (5) · Carcinoma (3) · Head and Neck Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Laryngeal Diseases (2) · Mouth Diseases (2) · Respiratory Tract Diseases (2)
Cisplatin (2) · Fluorouracil (2) · Gemcitabine (2) · 130-nm albumin-bound paclitaxel (1) · Cetuximab (1) · Chemoradiotherapy (1) · Endostatins (1) · Interferon beta-1a (1) · Nivolumab (1) · Patient Reported Outcome Measures (1) · Radiotherapy (1) · pembrolizumab (1)
German Society for Pediatric Oncology and Hematology GPOH gGmbH (1) · Guangxi Medical University (1) · Memorial Sloan Kettering Cancer Center (1) · University of California, San Diego (1) · Zhejiang Cancer Hospital (1)
United States (2) · China (1) · Germany (1)
Assuntina Sacco, M.D. (1) · C. Jillian Tsai, MD (1) · Udo Kontny, MD (1)